174 related articles for article (PubMed ID: 32078695)
1. CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies.
Melo AM; Conroy MJ; Foley EK; Dockry É; Breen EP; Reynolds JV; Lysaght J; Doherty DG
Cancer Immunol Immunother; 2020 Jun; 69(6):969-982. PubMed ID: 32078695
[TBL] [Abstract][Full Text] [Related]
2. Utilization of invariant natural killer T cells for gastric cancer treatment.
Xu Q; Li J; Zhang N; Zhang L; Qian R
Future Oncol; 2018 Aug; 14(20):2053-2066. PubMed ID: 30051730
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
4. Decreased invariant natural killer T-cell-mediated antitumor immune response in patients with gastric cancer.
Ascui G; Gálvez-Jirón F; Kramm K; Schäfer C; Siña J; Pola V; Cristi F; Hernández C; Garrido-Tapia M; Pesce B; Bustamante M; Fluxá P; Molina MC; Ribeiro CH
Immunol Cell Biol; 2020 Jul; 98(6):500-513. PubMed ID: 32189398
[TBL] [Abstract][Full Text] [Related]
5. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
6. Elevated Hepatic CD1d Levels Coincide with Invariant NKT Cell Defects in Chronic Hepatitis B Virus Infection.
Tan X; Ding Y; Zhu P; Dou R; Liang Z; Yang D; Huang Z; Wang W; Wu X; Weng X
J Immunol; 2018 May; 200(10):3530-3538. PubMed ID: 29643189
[TBL] [Abstract][Full Text] [Related]
7. iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .
Bassiri H; Das R; Guan P; Barrett DM; Brennan PJ; Banerjee PP; Wiener SJ; Orange JS; Brenner MB; Grupp SA; Nichols KE
Cancer Immunol Res; 2014 Jan; 2(1):59-69. PubMed ID: 24563871
[TBL] [Abstract][Full Text] [Related]
8. Porcine Invariant Natural Killer T Cells: Functional Profiling and Dynamics in Steady State and Viral Infections.
Schäfer A; Hühr J; Schwaiger T; Dorhoi A; Mettenleiter TC; Blome S; Schröder C; Blohm U
Front Immunol; 2019; 10():1380. PubMed ID: 31316500
[TBL] [Abstract][Full Text] [Related]
9. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.
Zeng J; Wang S
Stem Cells Transl Med; 2014 Jan; 3(1):69-80. PubMed ID: 24292792
[TBL] [Abstract][Full Text] [Related]
10. Innate immune control of EBV-infected B cells by invariant natural killer T cells.
Chung BK; Tsai K; Allan LL; Zheng DJ; Nie JC; Biggs CM; Hasan MR; Kozak FK; van den Elzen P; Priatel JJ; Tan R
Blood; 2013 Oct; 122(15):2600-8. PubMed ID: 23974196
[TBL] [Abstract][Full Text] [Related]
11. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.
Bosma A; Abdel-Gadir A; Isenberg DA; Jury EC; Mauri C
Immunity; 2012 Mar; 36(3):477-90. PubMed ID: 22406267
[TBL] [Abstract][Full Text] [Related]
12. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
13. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.
Mise N; Takami M; Suzuki A; Kamata T; Harada K; Hishiki T; Saito T; Terui K; Mitsunaga T; Nakata M; Ikeuchi T; Nakayama T; Yoshida H; Motohashi S
Cancer Sci; 2016 Mar; 107(3):233-41. PubMed ID: 26749374
[TBL] [Abstract][Full Text] [Related]
15. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
16. Fas/FasL interaction mediates imbalanced cytokine/cytotoxicity responses of iNKT cells against Jurkat cells.
Dou R; Hong Z; Tan X; Hu F; Ding Y; Wang W; Liang Z; Zhong R; Wu X; Weng X
Mol Immunol; 2018 Jul; 99():145-153. PubMed ID: 29783159
[TBL] [Abstract][Full Text] [Related]
17. Invariant NKT cells increase drug-induced osteosarcoma cell death.
Fallarini S; Paoletti T; Orsi Battaglini N; Lombardi G
Br J Pharmacol; 2012 Dec; 167(7):1533-49. PubMed ID: 22817659
[TBL] [Abstract][Full Text] [Related]
18. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
Yang G; Artiaga BL; Lewis ST; Driver JP
Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
[TBL] [Abstract][Full Text] [Related]
19. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
[TBL] [Abstract][Full Text] [Related]
20. CD1d-dependent, iNKT-cell cytotoxicity against keratinocytes in allergic contact dermatitis.
Balato A; Zhao Y; Harberts E; Groleau P; Liu J; Fishelevich R; Gaspari AA
Exp Dermatol; 2012 Dec; 21(12):915-20. PubMed ID: 23171451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
